Global Bile Duct Cancer Drug Market Size, Share, Trends & Growth Analysis Report Segmented By Targeted Therapy (Pemigatinib, Infigratinib (Phase 3), Ivosidenib (Phase 3), Immunotherapy (Pembrolizumab (Phase 3)), Others), Application, Disease Indication, Distribution Channel, And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034